1. Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions
   Christopher N. George et al, 2020, Journal of Bone Oncology CrossRef
2. Cellular immunotherapy strategies for Ewing sarcoma
   Claudia Rossig, 2014, Immunotherapy CrossRef
3. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
   Florian Lordick et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
4. Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
   Sareetha Kailayangiri et al, 2017, OncoImmunology CrossRef
5. Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival
   Kensuke Mitsunari et al, 2017, Oncology Letters CrossRef
6. Bisphosphonates in common pediatric and adult bone sarcomas
   Marie-Francoise Heymann et al, 2020, Bone CrossRef
7. Prospects for NK Cell Therapy of Sarcoma
   Mieszko Lachota et al, 2020, Cancers CrossRef